Intravenous morphine can avoid distressing constipation associated with oral morphine: A retrospective analysis of our experience in 11 patients in the palliative care in-patient unit

American Journal of Hospice and Palliative Medicine

Volumn 25, Issue 4, 2008, Pages 282-284

  Mazumdar, Ashish ^a   Mishra, Seema ^a,b   Bhatnagar, Sushma ^a   Gupta, Deepak ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cancer pain; Morphine metabolites; Oral morphine; WHO analgesic ladder

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

ARTICLE; CHEMICALLY INDUCED DISORDER; CONSTIPATION; DRUG EFFECT; FEMALE; GASTROINTESTINAL MOTILITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; NEOPLASM; ORAL DRUG ADMINISTRATION; PAIN; PALLIATIVE THERAPY; RETROSPECTIVE STUDY;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; CONSTIPATION; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN; PALLIATIVE CARE; RETROSPECTIVE STUDIES;

EID: 49749110347     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909108315913     Document Type: Article

References (23)

1. Raehal KM, Bohn LM Mu opioid receptor regulation and opiate responsiveness. AAPS J. 2005: 7; E587 - E591.
2. Vainio A., Ollia J., Matikainen E., Rosenberg P., Kalso E. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet. 1995; 346: 667-670.
3. Hanks GW Antiemetics for terminal cancer patients. Lancet. 1982; i: 1410.
4. Yuan CS, ed. Handbook of Opioid Bowel Dysfunction. New York: Haworth Medical Press; 2005.
5. Guststein HB, Akil H. Opioid analgesic. In: Hardman JG, Limbird LE, Gilman AG, eds. Goddman & Gilman's. The Pharmacological Basis of Therapeutics. 10 th ed. New York: MC Graw-Hill; 2001: 569-619.
6. McMillan SC Assessing and managing opiate-induced constipation in adults with cancer. Cancer Control. 2004; 11 (Suppl 1). 3-9.
7. Thompson AR, Ray JB The importance of opioid tolerance: a therapeutic paradox. J Am Coll Surg. 2003; 196: 321-324.
8. Hanks G., Cherny N., Fallon M. Symptom management. The management of pain: opioid analgesic therapy. In: Oxford Textbook of Palliative Medicine. 3 rd ed. New York: Oxford University Press; 2003.
9. Radbruch L., Sabatowski R., Loick G., et al. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med. 2000; 14: 111-119.
10. Ahmedzai S., Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS Fentanyl Comparative Trail Group. J Pain Symptom Manage. 1997; 13: 254-261.
11. Donner B., Zenz M., Tryba M., Strumpf M. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain. 1996; 64: 527-534.
12. Payne R., Mathias SD, Pasta DJ, et al. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine. J Clin Onocl. 1998: 16; 1588-1593.
13. Meissner W., Schimdt U., Hartmann M., Kath R., Reinhart K. Oral naloxone reverses opioid-assosiated constipation. Pain. 2000; 84: 105-109.
14. Derby S., Portenoy RK Assessment and management of opioid-induced constipation. In: Portenoy RK, Bruera E, eds. Topics in Palliative Care. New York: Oxford University Press; 1997: 95-112.
15. Yuan CS, Foss JF, O'Connor M., Osimski J., Roizen MF, Moss J. Effects of intravenous methylnaltrezone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study. Pain. 1999; 83: 631-635.
16. Slappendel R., Lako SJ, Crul BJP. Gastrointestinal side effects diminish after switch over from morphine to transdermal fentanyl. Ann Oncol. 1994; 5 (Suppl 8). 200.
17. Radbruck L., Sabatowski R., Loick G., Kulbe C., Kasper M. Use of laxative: a comparison between transdermal fentanyl and morphine. Palliat Med. 2000; 14: 111-119.
18. The TTS-fentanyl Multicentre Study Group. Transdermal fentanyl in cancer pain. J Drug Dev. 1994; 6: 93-97.
19. Megens A., Artois K., Vermeire J., Mert T. Awouters FH Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats. J Pain Symptom Manage. 1998; 15: 253-257.
20. Mercadante S., Casuccio A., Groff L., Boffi R., Villari P. Morphine to methadone to improve analgesia and tolerability in cancer patients. A prospective study. J Clin Oncol. 2001; 19: 2898-2904.
21. Mercadante S., Sapio M., Serretta R. Treatment of pain in chronic bowel subobstruction with self-administration of methadone. Support Care Cancer. 1997; 5: 327-329.
22. Daeninck PJ, Bruera E. Reduction in constipation and laxative requirement following opioid rotation to methadone: a report of four cases. J Pain Symptom Manage. 1999; 18: 303-309.
23. Mancini IL, Hanson J., Neumann CM, Bruera E. Opioid type and other clinical predictor of laxative dose in advanced cancer patients: a retrospective study. J Palliat Med. 2000; 3: 49-56.